Case Studies

Challenge: A rare-disease programme required parallel EMA and FDA filings under compressed timelines, with fragmented internal inputs and inconsistent narrative positioning across workstreams.

Solution: We embedded senior regulatory leadership to define the defensible evidence position first, aligning clinical summaries, CMC documentation, and cross-functional inputs around a coherent regulatory thesis before submission drafting began.

Impact: Submission-ready dossiers delivered on time, with reduced review cycle friction and clear alignment between agency expectations and internal strategy.

Challenge: A high-profile EU launch required a coherent scientific position across publications, field materials, and internal training, with fragmented inputs and inconsistent interpretation emerging across markets.

Impact: Stronger scientific clarity in external engagement, reduced internal review cycles, and consistent cross-market positioning during launch readiness.

Challenge: A global biologic programme approaching payer engagement lacked a unified economic narrative across HEOR evidence, value messaging, and regional HTA expectations.

Solution: We defined a payer-relevant value architecture first, aligning HEOR outputs, workshop materials, and cross-regional positioning around a coherent and defensible access thesis.

Impact: Stronger internal alignment, clearer payer-facing positioning, and more confident HTA discussions under scrutiny across regions.

Challenge: A new entrant to oncology needed a cohesive value narrative and launch materials for multi-stakeholder education.
Solution: Refined brand and scientific storytelling; built cross-functional assets for field and digital channels with MLR-ready copy.
Impact: Accelerated stakeholder uptake, reduced MLR friction, and a unified commercial narrative at launch.

Challenge: Pre-Series A company needed to convert strong science into a compelling, credible investor story.
Solution: Interviewed leadership, benchmarked peers, and created a crisp deck and capital narrative; coordinated warm introductions with investors, scheduled and facilitated investor calls, and represented the client through pre-, peri- and post-meeting discussions.
Impact: A sharper investment case, better-targeted outreach, and stronger investor engagement during the raise.